Literature DB >> 18667203

Neither antioxidants nor genistein inhibit the progression of established atherosclerotic lesions in older apoE deficient mice.

Michelle M Averill1, Brian J Bennett, Marcello Rattazzi, Rebecca M Rodmyre, Elizabeth A Kirk, Stephen M Schwartz, Michael E Rosenfeld.   

Abstract

Supplements and diets enriched in antioxidants and soy isoflavones are purported to reduce cardiovascular disease risk. Many experimental studies have demonstrated inhibitory effects of antioxidants and soy isoflavones on the development of fatty streaks in animal models. However, it is still unknown whether antioxidants and isoflavones have comparable inhibitory effects on the progression of advanced stages of atherosclerosis. This is an important question because clinical trials in humans have not supported a cardio-protective role for antioxidants or isoflavones. Thus, we examined the effects of antioxidants and genistein on the progression and composition of established, advanced atherosclerotic lesions in the innominate arteries (IA) of older apolipoprotein E-deficient (apoE(-/-)) mice. Thirty-week-old male apoE(-/-) mice were fed chow with or without genistein (0.27%, w/w) for 6, 12 and 24 weeks. Twenty-week-old male apoE(-/-) mice were fed chow with or without a cocktail of antioxidants (vitamin E 0.2%, w/w; vitamin C 0.05%, w/w; and beta carotene 0.5%, w/w) for 10, 16, and 22 weeks. There were no significant differences in total plasma cholesterol, body weight, average lesion or medial area, or changes in lesion composition with either treatment in comparison to control mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667203      PMCID: PMC2745123          DOI: 10.1016/j.atherosclerosis.2008.06.017

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  32 in total

1.  Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice.

Authors:  S R Thomas; S B Leichtweis; K Pettersson; K D Croft; T A Mori; A J Brown; R Stocker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

Review 2.  Genistein.

Authors:  Richard A Dixon; Daneel Ferreira
Journal:  Phytochemistry       Date:  2002-06       Impact factor: 4.072

3.  Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering.

Authors:  Florian Bea; Erwin Blessing; Brian Bennett; Michael Levitz; Elizabeth P Wallace; Michael E Rosenfeld
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

Review 4.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

5.  Antioxidant activity of isoflavones and their major metabolites using different in vitro assays.

Authors:  Corinna E Rüfer; Sabine E Kulling
Journal:  J Agric Food Chem       Date:  2006-04-19       Impact factor: 5.279

6.  The inhibitory effect of soy protein isolate on atherosclerosis in mice does not require the presence of LDL receptors or alteration of plasma lipoproteins.

Authors:  Michael R Adams; Deborah L Golden; Mary S Anthony; Thomas C Register; J Koudy Williams
Journal:  J Nutr       Date:  2002-01       Impact factor: 4.798

7.  Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan.

Authors:  C Nagata
Journal:  Int J Epidemiol       Date:  2000-10       Impact factor: 7.196

8.  Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts.

Authors:  Volker Viereck; Carsten Gründker; Sabine Blaschke; Heide Siggelkow; Günter Emons; Lorenz C Hofbauer
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

9.  Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice.

Authors:  Michael E Rosenfeld; Katalin Kauser; Baby Martin-McNulty; Patti Polinsky; Stephen M Schwartz; Gabor M Rubanyi
Journal:  Atherosclerosis       Date:  2002-10       Impact factor: 5.162

10.  Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway.

Authors:  X W Chen; S C Garner; J J B Anderson
Journal:  Biochem Biophys Res Commun       Date:  2002-07-12       Impact factor: 3.575

View more
  10 in total

1.  Vitamin E does not slow the progression of hypercholesterolemic atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2009

2.  Effect of chronic administration of vitamin E on the hemopoietic system in hypercholesterolemia.

Authors:  Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2010-06-04       Impact factor: 3.396

3.  Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Andrea Callegari; Yuhua Liu; Collin C White; Alan Chait; Peter Gough; Elaine W Raines; David Cox; Terrance J Kavanagh; Michael E Rosenfeld
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

4.  Vitamin E slows the progression of hypercholesterolemia-induced oxidative stress in heart, liver and kidney.

Authors:  Kailash Prasad; Erick D McNair; A Mabood Qureshi; Gudrun Casper-Bell
Journal:  Mol Cell Biochem       Date:  2012-06-20       Impact factor: 3.396

5.  Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial.

Authors:  Howard N Hodis; Wendy J Mack; Naoko Kono; Stanley P Azen; Donna Shoupe; Juliana Hwang-Levine; Diana Petitti; Lora Whitfield-Maxwell; Mingzhu Yan; Adrian A Franke; Robert H Selzer
Journal:  Stroke       Date:  2011-09-08       Impact factor: 7.914

6.  Effects of vitamin E on serum enzymes and electrolytes in hypercholesterolemia.

Authors:  Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2010-02       Impact factor: 3.396

Review 7.  Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes.

Authors:  Michelle M Averill; Karin E Bornfeldt
Journal:  Curr Diab Rep       Date:  2009-02       Impact factor: 4.810

Review 8.  Nutraceutical therapies for atherosclerosis.

Authors:  Joe W E Moss; Dipak P Ramji
Journal:  Nat Rev Cardiol       Date:  2016-07-07       Impact factor: 32.419

9.  Isoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic Disease.

Authors:  Rakesh P Patel; Stephen Barnes
Journal:  PPAR Res       Date:  2011-02-24       Impact factor: 4.964

10.  Prevention of atherosclerosis progression by 9-cis-β-carotene rich alga Dunaliella in apoE-deficient mice.

Authors:  Ayelet Harari; Revital Abecassis; Noa Relevi; Zohar Levi; Ami Ben-Amotz; Yehuda Kamari; Dror Harats; Aviv Shaish
Journal:  Biomed Res Int       Date:  2013-09-23       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.